Arizona objects to “stay of litigation” against Purdue Pharma and Sacklers
“If forced to bear the risk of adverse money judgments, the related parties may be unwilling — or unable — to make the billions of dollars of contributions contemplated by the settlement structure,’’ Purdue said in a filing last month.
Purdue Pharma has suggested in court filings that protecting the family from lawsuits is a vital component of the settlement. Purdue Pharma has asked the bankruptcy court to temporarily block thousands of lawsuits against Purdue and the Sackler family as a condition to allow the settlement to progress. It has said in court filings the Sackler family may walk away from the deal if it is not protected from the litigation.
Original Article (Washington Post):
OxyContin settlement snag: Arizona objects to stay of litigation against Purdue Pharma and Sacklers
Artwork Fair Use: Daderot